DE1793358A1 - Alkanolaminderivate und Verfahren zu deren Herstellung - Google Patents

Alkanolaminderivate und Verfahren zu deren Herstellung

Info

Publication number
DE1793358A1
DE1793358A1 DE19681793358 DE1793358A DE1793358A1 DE 1793358 A1 DE1793358 A1 DE 1793358A1 DE 19681793358 DE19681793358 DE 19681793358 DE 1793358 A DE1793358 A DE 1793358A DE 1793358 A1 DE1793358 A1 DE 1793358A1
Authority
DE
Germany
Prior art keywords
radical
carbon atoms
butyl
ethyl
radicals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19681793358
Other languages
German (de)
English (en)
Inventor
Smith Leslie Harold
Ralph Howe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of DE1793358A1 publication Critical patent/DE1793358A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19681793358 1967-09-07 1968-09-05 Alkanolaminderivate und Verfahren zu deren Herstellung Pending DE1793358A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40961/67A GB1199632A (en) 1967-09-07 1967-09-07 Alkanolamine Derivatives

Publications (1)

Publication Number Publication Date
DE1793358A1 true DE1793358A1 (de) 1972-11-09

Family

ID=10417463

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681793358 Pending DE1793358A1 (de) 1967-09-07 1968-09-05 Alkanolaminderivate und Verfahren zu deren Herstellung

Country Status (17)

Country Link
US (1) US3634511A (enExample)
JP (1) JPS5212182B1 (enExample)
AT (3) AT290502B (enExample)
BE (1) BE720544A (enExample)
CA (1) CA921917A (enExample)
CH (2) CH553156A (enExample)
CS (1) CS152306B2 (enExample)
DE (1) DE1793358A1 (enExample)
ES (1) ES357931A2 (enExample)
FR (1) FR327F (enExample)
GB (1) GB1199632A (enExample)
IE (1) IE32287B1 (enExample)
IL (1) IL30643A (enExample)
NL (1) NL6812681A (enExample)
NO (1) NO122074B (enExample)
SE (1) SE353318B (enExample)
SU (1) SU363241A3 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146558A (en) * 1966-05-23 1979-03-27 Sterling Drug Inc. Azo dyestuff intermediate nitro- or aminobenzenes ring-substituted by a quaternized amine alkyl or amino-alkoxy group
DE1957706C3 (de) * 1968-11-18 1978-06-29 Pfizer Corp., Colon (Panama) Kernsubstituierte 3-Phenoxy-l-phenoxyalkylamino-propan-2-ole und Arzneimittel auf deren Basis
US4059622A (en) * 1970-05-27 1977-11-22 Imperial Chemical Industries Limited Alkanolamine derivatives
US3959486A (en) * 1970-05-27 1976-05-25 Imperial Chemical Industries Limited Method for producing β-adrenergic blockage with alkanolamine derivatives
US4206144A (en) * 1971-11-22 1980-06-03 Sterling Drug Inc. N,N-Dialkyl-N-aminoalkyl-N-(amino or nitro)phenylalkyl- and N-methyl-N-[3-(amino or nitro)phenoxy-2-hydroxy-1-propyl]-N,N-bis(3-aminopropyl)quaternary ammonium salts
US3919424A (en) * 1972-02-16 1975-11-11 Mead Johnson & Co Bronchodilator process and composition
US3864398A (en) * 1972-05-01 1975-02-04 Teikoku Hormone Mfg Co Ltd Process for the preparation of acylamino alkanol derivatives
JPS5323826B2 (enExample) * 1972-05-15 1978-07-17
US4038414A (en) * 1972-06-08 1977-07-26 Ciba-Geigy Corporation Amines and processes for their manufacture
US3993776A (en) * 1973-10-15 1976-11-23 Mead Johnson & Company Anorexigenic process and composition
US3911007A (en) * 1974-08-08 1975-10-07 Searle & Co N-substituted N-benzyloxy-2-methyl-2-(4-halophenoxy)propionamides
MX158644A (es) * 1982-07-20 1989-02-21 Menarini Sas Procedimiento para preparar un derivado 1-alquilamina-3-(4(p-alquiloxibenzamida)-fenoxi)-2propanol
FI832377A0 (fi) * 1983-06-29 1983-06-29 Star Oy Ab Nytt foerfarande foer framstaellning av (r)-, (s)-eller (r,s)-1-(4'-alkylamido-2'-acetyl) fenoxi-3-alkylamino-2-propanoler
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
UY24949A1 (es) * 1997-04-08 2001-04-30 Smithkline Beecham Corp Compuestos calcilíticos

Also Published As

Publication number Publication date
CS152306B2 (enExample) 1973-12-19
GB1199632A (en) 1970-07-22
JPS5212182B1 (enExample) 1977-04-05
AT291969B (de) 1971-08-10
US3634511A (en) 1972-01-11
AT290502B (de) 1971-06-11
SE353318B (enExample) 1973-01-29
CH565137A5 (enExample) 1975-08-15
NO122074B (enExample) 1971-05-18
IL30643A (en) 1973-01-30
IE32287L (en) 1969-03-07
CA921917A (en) 1973-02-27
IE32287B1 (en) 1973-06-13
SU363241A3 (enExample) 1972-12-30
NL6812681A (enExample) 1969-03-11
ES357931A2 (es) 1970-04-01
BE720544A (enExample) 1969-03-06
CH553156A (de) 1974-08-30
FR327F (enExample) 1970-09-21
AT289765B (de) 1971-05-10
IL30643A0 (en) 1968-10-24

Similar Documents

Publication Publication Date Title
DE2015573C3 (de) a-Aminomethyl-3-(hydroxy-, acyloxy- oder acyloxymethyl)-4-acyloxybenzylalkohole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2136828C3 (de) 4-Phenoxy-phenoxyalkancarbonsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0188749A2 (de) Fumarsäurederivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE1493856B2 (de) 1-aryloxy-3-(n-alkylamino)-2-propanole, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
DE2164636C3 (de) N-(Phenoxyalkyl)-a-methylphenäthylamine, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2429101C3 (de) a-Isomeres des 2-Chlor-9- [3'-(N'-2hydroxyäthylpiperazino- N)-propyliden] -thioxanthens und dessen Ester, Verfahren zu deren Gewinnung bzw. Herstellung und diese Verbindungen enthaltende Mittel
DE1593027A1 (de) Alkensaeuren und Verfahren zu ihrer Herstellung
DE1815808A1 (de) Benzolderivate
DE1643424A1 (de) Alkanolaminderivate und Verfahren zu deren Herstellung
DE2212741B2 (de) 3 eckige Klammer auf (3 N Carbamoyl 2,4,6 trijod phenoxy) alkoxy eckige Klammer zu 2 alkylpropionsaure, deren physiologisch vertragliche Salze, Verfahren zu ihrer Herstellung und diese enthaltende Röntgenkontrastmittel
DE3818292A1 (de) Verfahren zur herstellung von isopropylidenderivaten eines polyglycerins
DE2723876A1 (de) 17 beta-ester von testosteron und 5 alpha-dihydrotestosteron
DE1468760A1 (de) Verfahren zur Herstellung von 4- und 5-Aryl-1-naphthalinessigsaeuren und deren Derivaten
DE1812906A1 (de) 4-Phenylbicyclo [2,2,2] octan und -oct-2-en-l-carbinole und -carboxaldehyde
AT344151B (de) Verfahren zur herstellung von neuen naphthalinderivaten
DE2122259A1 (de) alpha-Aminoalkyl-4-hydroxy-3-carboalkoxyaminobenzylalkohole, ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneipräparate
DE2647969A1 (de) Cyclische amide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE2028828A1 (de) Pyrazolopyridin carbonsauren und deren Derivate sowie Verfahren zu ihrer Herstellung und ihre Verwendung
DE2024049B2 (de) Alpha-(3,4-dihydroxyphenyl)-alpha(2-piperidinyl)-methanol
DE2403809C2 (de) 1-Aryloxy-2-hydroxy-3-alkinylaminopropane und Verfahren zu ihrer Herstellung und pharmazeutische Präparate
DE2803255A1 (de) Neue ergolin-verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
AT289764B (de) Verfahren zur Herstellung von neuen 1-(4'-Acylaminophenoxy)-2-hydroxy-3-aminopropanen sowie von deren Säureadditionssalzen
DE1543771A1 (de) 2-Hydroxy-3-subst.-propyl-1,4'-naphthochinone und Verfahren zu deren Herstellung
CH553155A (de) Verfahren zur herstellung von alkanolaminderivaten.
DE2741771A1 (de) Neue 2,2-dimethyl-19-nor-steroide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen